Rua Bioscience is trading 7.41% down at NZD 0.03, with no confirmed company-specific catalyst identified for October 8, 2026.

  • NZX shows no company announcements dated October 7 or 8.
  • The wider biotech sector was weak, with XBI down 2.04%; this is sector context, not a confirmed direct cause.
  • Rua’s rights trading was scheduled to close October 9, but available evidence does not establish it as the reason for the decline.